tirzepatide 3.75 mg Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial Tirzepatide Weight Loss Injections &
Description
If GLP-1 agonists can modulate this inflammation, thenat least theoreticallythey may help rebuild that system more effectively than anything weve tried so far
Wegovy contains semaglutide in different doses, so it is only used to support weight loss
Other common side effects include decreased appetite (which contributes to weight loss), abdominal pain, dyspepsia, and gastroesophageal reflux
Theres no guarantee that these small doses wont cause big problems
